Doctor profile · Federal record
Dr. Adriana Walsh, PA-C
Physician Assistant · Athens, OH
- NPI 1245446418
- Accepts Medicare
- MIPS 97.9 / 100 · 2023
- 22 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
75 Hospital Dr Ste 250
Athens, OH 457012866
(740) 566-4621
fax (740) 566-4622
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- May 23, 2012
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Ohio #50-003225
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1245446418. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,439
Distinct HCPCS
10
Medicare allowed
$197,255
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 7,000 | 26 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,756 | 322 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 878 | 684 | $74 | |
17000 |
Destruction of precancer skin growth, 1 growth | 541 | 444 | $43 | |
11102 |
Biopsy of related skin growth, first growth | 389 | 335 | $78 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 184 | 146 | $46 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 132 | 32 | $1 | |
11103 |
Biopsy of related skin growth, each additional growth | 106 | 73 | $39 | |
17110 |
Destruction of skin growth, 1-14 growths | 95 | 78 | $89 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 84 | 84 | $92 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 390. This provider delivers 29× the peer median.Open Payments
Industry payments received
All-time total
$4,027
Transactions
123
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 16 | $1,695.36 | |
| ABBVIE INC. | 28 | $442.33 | |
| GENZYME CORPORATION | 11 | $312.21 | |
| E.R. Squibb & Sons, L.L.C. | 14 | $232.89 | |
| Novartis Pharmaceuticals Corporation | 11 | $222.86 | |
| Lilly USA, LLC | 8 | $211.62 | |
| UCB, Inc. | 5 | $133.60 | |
| Incyte Corporation | 7 | $122.38 | |
| Arcutis Biotherapeutics, Inc. | 3 | $93.64 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $85.00 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $79.38 | |
| Amgen Inc. | 4 | $73.10 | |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $69.01 | |
| Dermavant Sciences, Inc. | 4 | $60.14 | |
| LEO Pharma Inc. | 3 | $55.44 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
877
Patients
531
Total drug cost
$1,138,732
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 156 | 124 | $1,315 |
| Ketoconazole | Generic | 110 | 60 | $2,455 |
| Betamethasone Dipropionate | Generic | 107 | 74 | $5,022 |
| Clobetasol Propionate | Generic | 96 | 53 | $5,053 |
| Doxycycline Monohydrate | Generic | 71 | 61 | $1,978 |
| Metronidazole | Generic | 42 | 29 | $3,349 |
| Humira(Cf) Pen (Adalimumab) | Brand | 40 | 0 | $577,902 |
| Imiquimod | Generic | 40 | 34 | $1,726 |
| Mupirocin | Generic | 40 | 34 | $340 |
| Dupixent Pen (Dupilumab) | Brand | 38 | 0 | $146,934 |
Hospital affiliations
Frequently asked questions
What is Dr. Adriana Walsh's medical specialty?
Dr. Adriana Walsh practices Physician Assistant in Athens, OH.
Where does Dr. Adriana Walsh practice?
Dr. Adriana Walsh practices at 75 Hospital Dr Ste 250, Athens, OH 457012866. Office phone: 7405664621.
What is Dr. Adriana Walsh's NPI?
Dr. Adriana Walsh's National Provider Identifier (NPI) is 1245446418, issued by NPPES.
Does Dr. Adriana Walsh accept Medicare assignment?
Yes. Dr. Adriana Walsh accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Adriana Walsh commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.